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ABSTRACT 
Purpose: To investigate whether an initial non-water-suppressed acquisition that provides 
information about the signal-to-noise ratio and linewidth is enough to forecast the maximally 
achievable final spectral quality and thus inform the operator whether the foreseen number of 
averages and achieved field homogeneity is adequate. 
Methods: A large range of spectra with varying signal-to-noise and linewidth was simulated and 
fitted with popular fitting programs to determine the dependence of fitting errors on linewidth and 
signal-to-noise. A tool to forecast variance based on a single acquisition was developed and its 
performance evaluated on simulated and in vivo data obtained at 3 T from various brain regions 
and acquisition settings.  
Results: A strong correlation to real uncertainties in estimated metabolite contents was found for 
the forecast values and the Cramer-Rao lower bounds obtained from the water-suppressed 
spectra. 
Conclusion: It appears to be possible to forecast the best-case errors associated with specific 
metabolites to be found in model fits of water-suppressed spectra based on a single water scan. 
Thus, non-specialist operators will be able to judge ahead of time whether the planned 
acquisition can possibly be of sufficient quality to answer the targeted clinical question or 
whether it needs more averages or improved shimming. 
 
 
Keywords: MR spectroscopy; brain; quantification error; SNR, LW, quality 
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List of Abbreviations 
Asp, Aspartate 
Cho, Choline 
Chotot, total Choline (GPC + PCho) 
Cr, Creatine 
Crtot, total creatine (Cr + PCr) 
GABA, γ-aminobutyric acid 
Glc, Glucose 
Gln, Glutamine 
Glu, Glutamate 
Glx, Glutamate + Glutamine 
GPC, Glycerophosphocholine 
GSH, Glutathione 
Gly, Glycine 
HLSVD, Hankel-Lanczos Singular Value 
Decomposition 
jMRUI, Java version of the magnetic 
resonance user interface 
Lac, Lactate 
mI, Myo-inositol 
mItot, Myo-inositol + Glycine 
NAA, N-acetylaspartate 
NAAG, N-acetylaspartyl-glutamate 
NAAtot, total NAA (NAA + NAAG) 
nWS, Non-water-suppressed 
PCho, Phosphocholine 
PCr, Phosphocreatine 
PRESS, Point resolved spectroscopy 
QUEST, Quantitation based on quantum 
estimation 
sI, Scyllo-inositol 
SD, Standard deviation 
SNR, Signal-to-noise ratio 
SVS, Single voxel spectroscopy 
Tau, Taurine 
VESPA, Versatile simulation- pulses and 
analysis 
VOI, Volume of interest 
WS, Water-suppressed 
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INTRODUCTION 
Magnetic resonance spectroscopy (MRS) is a non-invasive method that can provide clinically 
relevant metabolic information (1). Despite the evidence for the value of MRS in clinical practice 
and despite of technical improvements, the application of MR spectroscopy is still limited 
because of its challenging nature of interpretation, expert knowledge requirement (2), but also 
because of time constraints in the clinical setting.  
Relative to MRl, MRS has much lower sensitivity and thus requires much longer acquisition 
times. In addition, MRS requires a more homogeneous B0 field than MRI to achieve sufficient 
separation of metabolite resonances, hence necessitating dedicated shimming for each region 
of interest (ROI) – again prolonging overall acquisition time.  
The quantification of in vivo localized proton MR spectra is affected by the signal-to-noise ratio 
(SNR), broadened line shapes due to inadequate shimming, presence of a non-flat baseline 
often related to insufficient water suppression, and inherent limits of the contributing spectral 
components, including overlapping peaks, and the incomplete prior-knowledge in particular with 
regard to the macromolecular baseline. From the experimental factors, linewidth (LW) and SNR 
may serve as the main physical measures to rate the quality of spectra (2). The effects of SNR 
and LW on metabolite concentrations have been investigated at 1.5 T and 4 T (3,4) to show that 
as SNR decreases or the linewidth broadens, the quantification accuracy clearly decreases. 
These results suggest that – within limits – knowledge of SNR and LW alone may serve to 
forecast the achievable quantification accuracy, if other parameters such as patient motion, 
scanner drift, degrading effects of water suppression, etc., do not interfere for the longer 
acquisition of the water-suppressed spectrum. Knowledge of the achievable quantification 
accuracy before actual acquisition of a water-suppressed spectrum may substantially influence 
the course of clinical MR examinations. 
In present clinical routine, the usual protocol consists of choosing the ROI to acquire the 
spectrum from, optimizing acquisition settings, including shimming, followed by acquisition of 
the water-suppressed spectrum and - usually afterwards - acquisition of a single-shot water-
unsuppressed spectrum for referencing. If expert knowledge is available at that time, a real time 
evaluation of spectral quality may influence the decision to acquire more repetitions to improve 
SNR or to change location to improve the shim. If at this point or later in off-line post-processing 
data quality is found to be insufficient, the scanner/patient time used (including shimming, voxel 
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placement, and actual scanning) is wasted and often there is no time and opportunity to re-
record the spectrum with better-suited acquisition parameters. 
Particularly for focal lesions where the size and location of the ROI is different from case to 
case, even for the expert, it is not straightforward to forecast how long signals should be 
averaged and how well the ROI has to be shimmed in order to arrive at an interpretable 
spectrum for the particular clinical question. The operator would have to take into account 
factors like the size of the ROI, the quality of the shim (influenced by proximity to skull/bone/air 
transitions, or presence of blood), the field strength and other hardware specifics. However, 
achievable SNR and LW can essentially be known from a single water-unsuppressed 
acquisition and if this reference data is acquired before the lengthy recording of water-
suppressed data, the decision to go ahead could be taken on more objective grounds. In 
addition, using the square root dependence of SNR with regard to the number of averages (2), 
the water signal could be used as basis to forecast how many signal averages will be needed, 
to achieve a minimally required quantification precision.  
In this study, the effects of SNR and LW on metabolite concentrations at 3 T were modeled and 
it was investigated whether this information could be used to forecast the best achievable 
modeling inaccuracies for the metabolites of interest before the relevant water-suppressed data 
is recorded and thus to influence the acquisition parameters for the subsequent acquisition of 
the water-suppressed spectrum. The performance of the forecast was investigated using 
simulated spectra and then verified for in vivo spectra of human brain for all major metabolites, 
including myo-inositol and glutamate.  
 
METHODS 
Simulation 
Brain metabolite spectra were simulated in Vespa (5) using spin Hamiltonian parameters of 
metabolites (6,7) for ideal short and long echo time PRESS localization (echo times (TEs) 30 
ms and 136 ms) and scaled to yield a normal brain spectrum based on concentrations and T2 
values from literature (8,9). Simulated metabolites for short TE included aspartate (Asp), γ-
aminobutyric acid (GABA), creatine (Cr), glucose (Glc), glutamate (Glu), glutamine (Gln), 
glycine (Gly), glycerophosphocholine (GPC), glutathione (GSH), lactate (Lac), myo-inositol (mI), 
N-acetylaspartylglutamate (NAAG), N-acetylaspartate (NAA), phosphocholine (PCho), 
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phosphocreatine (PCr), scyllo-inositol (sI), taurine (Tau). Asp, GABA, Glc were not included for 
long TE spectra due to their T2-attenuated minor contributions. Similarly, a water spectrum was 
simulated and scaled using a T2 for water of 80 ms (10) and an assumed water content 
specified by the user (see below). The linewidths for the simulated base spectra of metabolites 
and water were 2 and 4 Hz, respectively. 
 
A macromolecular baseline (MMBL) signal was also added for the simulated short TE spectra. 
The MMBL had been acquired from 10 human subjects in a 2DJ experiment with the metabolite-
nulling technique (11) using an inversion time of 900 ms and TEs ranging from 20 to 95 ms. For 
the short TE baseline spectrum, the macromolecule spectra from TE=25, 30, and 35 ms were 
averaged to create an approximate TE=30 ms spectrum. The MMBL spectrum was 
preprocessed to remove water and metabolite residuals using Hankel-Lanczos Singular Value 
Decomposition (HLSVD). Then the MMBL spectrum was modeled as sum of Lorentzians by 
HLSVD with restraints on damping constants to obtain a noiseless representation of the MMBL 
spectrum. The linewidths of the base components of this MMBL spectrum were then adjusted to 
match a metabolite spectrum of 2 Hz width.  
 
These in silico spectra (water and metabolites) were used to generate spectra with different LW. 
First, the water spectrum was apodized to feature LWs ranging from 5 to 15 Hz in 1 Hz 
increment, using different Gaussian damping factors. The same damping factors were then 
applied to the corresponding metabolite spectra. 
 
For each LW, 100 spectra of different noise realizations were created to obtain data sets at 18 
SNRs ranging from 5 to 300 (5, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90, 100, 125, 150, 175, 200, 
250, 300), where SNR was defined in time domain (TD) as amplitude of the first point of the 
overall metabolite signal divided by the standard deviation of the noise in the TD signal. In total, 
19800 spectra were created for both short and long TE. 
 
Quantification 
Simulated spectra were quantified using the two most widely used fitting packages (LCModel 
(12) and jMRUI (QUEST) (13)). QUEST is a pure TD method whereas LCModel is using the 
frequency domain (FD) for least squares minimization (14).  
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LCModel works fully automatic and operator-independent to decompose an in vivo spectrum 
into a linear combination of model spectra provided as prior knowledge. It also estimates a 
flexible lineshape model and a spline baseline that accounts for model imperfections (12,15). In 
this study, LCModel was used in the standard configuration with the analyzing window from 
0.2 to 4 ppm. 
 
QUEST also quantifies spectra by utilizing model spectra as prior knowledge. To accommodate 
a baseline it uses a three step procedure. It is assumed that the background signals have short 
T2 and therefore truncating the initial points would separate the background from the metabolite 
signals (16,17). So first, initial points are truncated and the metabolite parameters are estimated 
on the truncated fid. The fitted truncated signal is then back-projected to the time origin and 
subtracted from the original signal to get the noisy background signal. In the second step, the 
noisy background signal is modeled by Lorentzian components using SVD. In the third step, the 
parameterized background signal is either subtracted from the raw signal or – as applied here - 
used as a further model component (option “InBase”) and a parametric nonlinear least-squares 
fit is performed in TD. In our study, the linewidth parameter was allowed to range between -10 
and +150 Hz while frequency shifts were not allowed, assuming previous overall alignment and 
no relative shifts of metabolite components. The ‘InBase’ option was chosen with 5 truncation 
points, which was found optimal to model very broad baseline components for the case where 
the MMBL are handled by including a MMBL spectrum in the basis set. .  
 
Both methods yield estimates for metabolite content along with Cramer-Rao lower bounds 
(CRLB) for the fitting errors. CRLB (18) reflect minimal uncertainties for each fit as given by the 
interdependence of fitting parameters in the model and the experimental noise level associated 
with the measurement.  The CRLB represent the lowest possible error, with overall uncertainties 
bound to be larger because of additional experimental uncertainties.  
 
Prior knowledge for the quantification included the information describing all resonances present 
in the simulated spectra. For short TE spectra, the MMBL spectrum was also included as basis 
spectrum since it has been shown (19) that inclusion of a metabolite-nulled spectrum in the 
basis set leads to more reliable and accurate metabolite quantification than using the estimated 
MMBL from LCModel. For QUEST, at both long and short TE, the prior knowledge did not 
include separate Cr and PCr but rather a sum of Cr and PCr (50:50), in order to obtain an 
estimate and CRLB of total creatine (Crtot = Cr +PCr).  
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The median CRLB, median bias (fit minus true values) and the standard deviations (SD) of 
metabolite contents across 100 spectra were calculated for each combination of LW and SNR 
and tabulated for the forecasting tool. The medians were preferred over averages for their 
insensitivity to single cases where the fit algorithm may not have found the global χ2 minimum. 
 
The absolute concentrations and CRLB error estimates were calculated with respect to water. 
LCModel provides the CRLB in percent, so to express them in absolute values; they were 
multiplied with the estimated concentrations.  
 
Forecast tool 
For forecasting metabolite errors in the form of CRLB of fitted spectra for metabolite content 
based on the water spectrum, first the linewidth of the experimental non-water suppressed 
spectrum was determined by fitting the signal to a Voigt lineshape. Then the expected SNR of 
the metabolite spectrum was calculated based on the proposed number of averages, the TE 
and the water content (WC) of the ROI as indirectly indicated by the user as relative white and 
gray matter content of the ROI. 75% water content in pure gray matter and 65% in pure white 
matter were assumed. (T1-relaxation effects and CSF contributions to the water signal are 
currently neglected in this prototype tool). 
 
Equation 1 shows how the expected TD SNR of the metabolite spectrum was calculated based 
on a single acquisition of the water signal. 
 
                    Expected	SNR	of	metabolite	TD	signal =  !" #$%&'(%)'*/	,- [1] 
where  
 SNR./012	 is the SNR in the single shot water signal, 
  K = 45404/6	7/85409:1	;<	=>	?485/6	;<	?4796/01:	./01245404/6	7/85409:1	;<	=>	?485/6	;<	?97	;<	?4796/01:	710/@;6401	?485/6?. 
and averages stands for the prescribed number of acquisitions for the water-suppressed 
spectrum. 
 
Using LW and the SNR information, the errors associated with each metabolite concentration 
estimate were determined by interpolation of the tabulated values. 
The whole procedure of forecasting is shown in a flowchart in Figure 1 
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Performance testing  
In-silico 
To test how well the forecast works at best, the water spectra simulated with varying LWs and 
SNRs were treated as experimental spectra to forecast the metabolite errors for the associated 
metabolite spectra. The differences with respect to CRLB as well as the true variance found in 
the model fits were investigated as a function of LW and SNR for both short and long TE. 
 
In-vivo 
The forecast tool was then applied to in-vivo cases. Twelve healthy subjects (4 women and 8 
men) gave informed consent according to the procedure approved by the local ethics 
committee. The scans were performed on 3-T scanners (Trio and Verio, Syngo MR VB17 
Siemens, Erlangen, Germany) using 16 channel phased array receive-only head coils. Each 
measurement session included basic MRI to define the ROIs for MRS. First- and second-order 
shims were adjusted using FASTESTMAP (20). Water suppressed, as well as unsuppressed 
spectra were acquired using a standard PRESS sequence at TE = 30 ms and 136 ms, TR = 
3000 ms, number of acquisitions ranging from 16 to 128, ROI size ranging from 1.6 to 9.1 cm3 
(with typical dimensions from 16x10x10 mm3 to 40x19x12 mm3) and from different parts of the 
brain (frontal, occipital, supraventricular) containing both white matter and gray matter. 
 
The in vivo spectra were analyzed using jMRUI and LCModel with parameters set as described 
for the simulated datasets. For jMRUI, preprocessing included eddy current-correction using the 
phase information of the water spectrum and removal of residual water using HLSVD 
decomposition. In LCModel, the option to do eddy-current-correction using the phase 
information of the water reference was chosen. Residual water was not removed.  
 
RESULTS 
Forecasting with LCModel 
LCModel was able to quantify all 19800 simulated metabolite spectra at short and long TE. 
Figure 2 shows representative spectra and fit results from the large set of simulated spectra, 
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illustrating that LCModel (left panel) did not yield substantial systematic residuals in any of the 
situations, i.e. neither for a spectrum with substantial noise (SNR 20) in row a, nor the noiseless 
cases without broadening (row b) or with 10 Hz Gaussian broadening (row c), where LCModel 
profits from a flexible shape estimation with sufficient freedom to adapt to Gaussian broadening.  
Systematic residuals would lead to bias for the estimated metabolite contents. The median bias 
expressed as percentage of the true concentrations was found to be very small or even 
negligible for LCModel at short TE with +3%, +2%, +3%, +4%, -3% and <1% for Crtot, NAAtot, 
Glu, Glx, mItot and Chotot, respectively. Similar results were found at long TE. 
Figure 3 and Figure 4 illustrate the database used for developing the forecast tool with esti-
mated CRLB and true variance found when fitting the simulated spectra. The true variance i.e. 
the SDs of metabolite estimates across the 100 spectra for each particular combination of LW 
and SNR was compared to the CRLB given by the fitting tool. These figures show the average 
CRLB (on the left) and true variance in estimated metabolite content (on the right) as a function 
of LW and SNR for a selection of metabolites in the cases of short (LCModel results in Fig 3a) 
and long (Fig 4a) TE. As expected, uncertainties of estimated metabolite contents, reflected in 
CRLB and true variance, generally increase when the lines broaden or SNR decreases. CRLB 
and true variance show similar values and dependences for LCModel. In general, it was found 
that the CRLB somewhat overestimate the variance of fitting results. In particular at TE 30 ms, 
the ratio between CRLB and true SD was between 1.05 and 1.29 for the major metabolites. 
Looking into the detailed dependence of the comparison between CRLB and true variance on 
linewidth, we find that e.g. for Crtot, the ratio increased from 1.1 at FWHM of 5 Hz to 1.3 at 
15 Hz. 
These sets of CRLB and true variance were then translated into large lookup tables for 
expected errors based on estimated SNR and LW of the related single shot water signals. Figs 
3 and 4 represent these look-up tables. To judge the in silico performance, the mean absolute 
difference between the forecast error based on the water signal and the actual error found from 
the fits was evaluated. At short TE, the maximum difference was just 1% for LCModel, such that 
from the synthetic data it appears that an error forecast based on the water signal seems 
feasible for many metabolites. 
The proposed scheme was verified on in vivo spectra that had SNR and FWHM ranging from 5 
to 190 and 5 to 14 Hz, respectively. Example in vivo data is shown in Figure 5 with different 
LWs, SNRs, voxel location and TEs. The top row shows the initially acquired water scan with 
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estimated linewidth and SNR. The middle row presents the predicted CRLB values from the 
look up table and simulated water-suppressed spectra that closely match the corresponding LW 
and SNR. The bottom row illustrates the subsequently actually acquired in vivo metabolite 
spectra and the CRLB values obtained for their fits. Figures 6 to 7 document the outcome for all 
in vivo cases by presenting the correlation between the predicted CRLB based on the water 
acquisition and those found from the fitting results of the actually recorded WS spectra for some 
metabolites. In addition, a Bland-Altman plot is added for each correlation to investigate 
potential systematic deviations. Results are illustrated for short (Figure 6) and long (Figure 7) 
TE. The coefficients range between 0.73 and 0.91 for the metabolites shown. The Bland-Altman 
plots show a very small but significant offset for some of the metabolites and no significant bias 
for others. The confidence intervals for the deviation between forecast and actual errors as 
given in the plots range between ±0.03 mM (Chtot) and ±0.3 mM (Glu and Glx) for the case of 
short TE in LCModel. The situation is similar at long TE. 
 
Forecasting with jmrui/QUEST 
The major outcome was similar when using QUEST instead of LCModel, but the fact that 
QUEST is restricted to Lorentz-broadening lead to larger systematic deviations and a weaker 
performance for the CRLB forecasts. The major differences to LCModel are presented in detail 
in the following.  
QUEST was able to quantify all long TE spectra, but failed for 2.6% of the short TE cases. Fit 
results for jMRUI’s QUEST (Figure 2 right panel) are similar to those of LCModel in cases with 
substantial noise (row a), and also for the noiseless case without broadening (row 2b). 
However, residuals are much larger for QUEST for a case with 10 Hz Gaussian broadening 
(row 2c), where the Voigt lines are dominated by the Gaussian broadening but are fitted with a 
purely Lorentzian lineshape model. 
These systematic residuals are reflected in substantial bias for the estimated metabolite 
contents in the synthetic spectra for some of the investigated cases. The median bias at short 
TE was found to be much larger for QUEST than for LCModel with values of +32% and +29% 
for Crtot and Glu compared to +3% for both cases when using LCModel. 
For QUEST, the comparison between average CRLB (on the left in Figs 3 and 4) and true 
variance (on the right in Figs 3 and 4) as a function of LW and SNR is hampered by the fact that 
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QUEST does not provide CRLB estimates for sums of metabolites, but - where available - the 
differences between true variance and estimated CRLB are larger for QUEST than for LCModel. 
As with LCModel, it was found that the CRLB overestimate the variance of fitting results 
systematically. However for QUEST, even though the noise was calculated using the original 
data and not the residues, the ratio between CRLB and true SD was larger and in the range of 
2.1 to 3 compared to below 1.3 for LCModel.  
Looking at the in silico performance, the mean absolute difference between the forecast error 
and the actual error was found to be somewhat larger for QUEST than LCModel (maximum 
difference of 8 vs. 1%), but still small enough to promise valid results also for QUEST.  
Results for the in-vivo performance of error forecasts using QUEST are illustrated for short TE 
(Figure 8) and long TE (Figure 9). For QUEST, correlation coefficients range between 0.78 and 
0.89, similar to the values for LCModel while Bland-Altman plots similarly show small but 
significant offsets for some metabolites. The confidence intervals for these deviations (see Figs 
8-9) are again somewhat larger for QUEST. 
 
DISCUSSION 
A water-unsuppressed signal is nearly always recorded in clinical MRS investigations and can 
be used as a reference for lineshape correction and as an internal reference for absolute 
metabolite quantitation. Here, we show that it is also possible to use such a single-shot water 
signal to forecast an estimate for the quantification error that will be associated with the fitting 
result for most relevant metabolites from the subsequently recorded water-suppressed 
spectrum. The forecast is based on the linewidth and SNR of the water data, as well as the 
planned number of acquisitions.  
Clinical MRS exams are most often performed by non-expert personnel. They cannot judge the 
quality of the acquired water scan or spectrum and thus whether or not any targeted question 
about potential changes in metabolite content could possibly be answered given the foreseen or 
even the already acquired spectrum. The possibility to forecast fitting errors would allow defining 
minimal quality prerequisites to be fulfilled for an MR spectrum to be recorded under the 
planned acquisition settings. In particular, this may allow the non-specialist (and even the 
experienced user) to better judge in real time, i.e. with the patient still in the scanner, how many 
acquisitions should be prescribed for a certain clinical question, or whether under the given 
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circumstances the ROI should be increased or possibly moved away from areas of potential 
susceptibility problems to obtain narrower linewidths. If quality screening is only performed after 
acquisition of the WS spectrum, time will often not allow for improved or prolonged spectral 
acquisitions and of course if spectral processing is done off-line, enhanced or longer 
acquisitions are not feasible.  
Not very surprisingly, the forecast worked very well for the synthetic cases, also when 
comparing the observed variance from fitting 100 different spectra per case with the forecast 
CRLB. But as evident from Figs. 6 to 9, the error forecast showed very good accuracy also in 
vivo. For reasons of limited space, the results were only presented for the clinically most 
interesting metabolites (and for this reason primarily for the more accurately defined sums of 
metabolites with a similar spectrum) at both echo times, but results are similar for the other 
metabolites and there is no reason why it could not be used for any metabolite or other 
acquisition condition, if needed.  
However, the value of the forecast is limited in several aspects. 1) The forecast errors provide a 
best case scenario. If the patient moves, or acquisition conditions are not constant for other 
reasons, the forecast may be incorrect. Also, if the WS spectrum should be plagued by artifacts 
(2), the best case scenario would not apply – thus the proposed tool should only be seen as a 
minimal quality requirement, not as a guarantee for eventual success of the MRS exam. In fact, 
it should be seen as a warning system for likely failure, not as an indicator of probable success. 
2) The proposed forecast tool should be implemented in a real time version, best on the scanner 
console or at least with automatic transfer and evaluation on a satellite station next to the 
scanner, since otherwise the time benefit would be wasted. 3) For each clinical question a 
threshold uncertainty has to be predefined requiring the experience of previous investigations, 
but this can be defined based on literature data. 4) The currently presented forecast is based on 
spectra that are composed of those metabolites that occur in healthy brain. Interference with 
other spectral elements, e.g. lipid resonances, may be investigated in addition. 
Further limitations concern general issues of fitting MR spectra, where it is known that results 
will depend on the fitting and processing routines used and in particular the prior knowledge 
constraints included. Hence the forecast errors will only be applicable if an evaluation similar to 
the one used to define the forecast tool is being used. This has become evident from the 
comparison of the LCModel and QUEST results, as described above. In particular, baseline and 
lineshape issues may well modify the results and the effective fitting error drastically. The 
baseline signals pose a challenge for obtaining reliable estimates, because they may have 
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unknown shapes and intensities and may include lipids. The macromolecules and lipids also 
vary based on pathologies (21–25). Accurate estimation of macromolecules is needed for 
reliable quantification of metabolites. For the synthetic spectra used in this study, this was 
confirmed when comparing different evaluation schemes for both LCModel and QUEST, when 
we did or didn’t use a macromolecular baseline as part of the basis set (results not shown). For 
QUEST, the results depended heavily on the algorithm of baseline incorporation (e.g. number of 
initial data points to use for baseline definition). In particular, the baseline is a serious problem 
when the spectral resolution is low. Over- or underestimation of the macromolecule signal may 
strongly influence content and CRLB of the overlapping metabolites with broad spectral 
patterns. It should also be noted that the forecast errors as defined in the present set up would 
not be correct in cases of pathology, when other base spectra would be introduced, or lipids 
would have to be included in the fit. 
The lineshape due to the remaining field inhomogeneity after shimming is often non-Lorentzian 
and thus fitting with pure Lorentzians easily leads to systematic errors (26). Experimental 
lineshapes are more precisely modeled by a Voigt function (multiplication of Lorentzian and 
Gaussian damping). Hence, we used the Voigt lineshape to fit the water spectrum for the 
determination of the water linewidth. If the true LWs deviate from this model, this might impact 
on the forecast. This is currently not considered, but a check of lineshape could be included in 
the forecast. The fact that QUEST in its current form did not allow for use of Voigt lines or 
general lineshapes certainly is the reason why it showed considerable bias. In contrast, 
LCModel uses a regularized lineshape model that accounts for the unknown lineshapes thus 
reducing effects of lineshape on bias. The effect of the used lineshape is evident in Fig. 2.  
A minor issue that has not been treated in depth so far is the exact water content of the 
investigated ROI. At present, this is included indirectly with the user describing the ROI content 
in terms of white/grey matter percentage. Using a proton density map – possibly augmented 
with automatic tissue segmentation, this could be circumvented, such that also for cases of 
cysts and necrosis proper scaling could be achieved (27).  
The fitting results from the vast set of simulated spectra with differing SNR and LW also yielded 
insight into the performance of LCModel and QUEST as well as into general dependence of fit 
results on LW and SNR. Figs 3 -4 illustrate this dependence with the diagrams on true variance 
(right side panels). The outcome is similar to earlier investigations (3,4). It should be noted that 
these diagrams depend strongly on whether the SNR is defined in time or frequency domain. 
Here we have used the TD definition, because in this way SNR does not depend on the 
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linewidth. With the FD definition of SNR, constant SNR with variable linewidth implicate differing 
acquisition times. Thus, in the presented figures, one can observe the expected larger variance 
for an increase in linewidth whereas if the SNR is defined in frequency domain, one may even 
detect a decrease in the measurement error with increased linewidth just because this mixes 
the effect of linewidth and length of acquisition time. 
From Figs 3 and 4, it seems that the absolute error for long TE is generally lower than for short 
TE. This is only true for identical SNR, but to achieve similar SNR in these particular cases, it 
would roughly take at least twice as long at the longer TE. Hence, for equal acquisition times, 
the fitting errors for those compounds that can be measured at both echo times would probably 
be about the same. 
As an outlook, the performance of this forecast tool might be optimized by use of actual in vivo 
data as part of the look-up table, where one might also improve the performance by including 
lineshape characteristics other than the simple LW and possibly machine learning algorithms for 
the predictor. 
In conclusion, our results indicate that it is possible to forecast the errors associated with 
specific metabolites to be found in model fits of WS spectra based on a single shot water signal. 
Thus, the clinical MRS user will be able to judge ahead of time whether the planned acquisition 
can possibly be of sufficient quality to answer the question at hand or whether it needs more 
averages or improved shimming. 
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Figure Captions 
Figure 1: Flowchart illustrating the forecasting procedure. The steps marked in blue are 
calculated by the toolbox while the steps marked in pink represent input by the user. 
 
Figure 2: Illustration of the fits in LCModel and QUEST for simulated PRESS 1H-MR spectra at 
TE=30 ms. a) FWHM = 7 Hz, SNR = 20; b) FWHM = 2 Hz (Lorentzian lineshape), no noise 
added; c) FWHM = 10 Hz (Voigt lineshape), no noise added. The residuals (original spectrum 
minus fit) are shown above the spectra. For QUEST, the original spectra and their 
corresponding fits were zero-filled before plotting for better comparison, since zero-filling is part 
of the LCModel data treatment. 
 
Figure 3: Mean variance for some estimated metabolite content obtained for simulated spectra 
at short TE when fit with LCModel (a) and QUEST (b). For both cases, the mean CRLB is 
shown on the left and standard deviations of the determined metabolite contents as obtained 
over 100 different noise realizations on the right. 
Since QUEST does not provide error estimates of summed metabolite areas, some diagrams 
are missing. It should also be noted, that for Crtot (where we do indicate CRLB values even in 
the case of QUEST), we had included a base spectrum for a 50/50 mixture of Cr and PCr, 
rather than individual spectra in the case of QUEST. 
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Abbreviations: Chotot = Glycerophosphocholine + Phosphocholine; Cr = Creatine; CRLB = 
Cramer-Rao-lower bound; Crtot = Creatine + Phosphocreatine; Glx = Glutamate + Glutamine; 
mItot = myo-Inositol + Glyine; NAAtot = N-acetylaspartate + N-acetylaspartyl-glutamate; PCr = 
Phosphocreatine; TrueSD= true standard deviation. 
 
Figure 4: Mean variance for some estimated metabolite content obtained for simulated spectra 
at long TE when fit with LCModel (a) and QUEST (b). For both cases, the mean CRLB is shown 
on the left and standard deviations of the determined metabolite contents as obtained over 100 
different noise realizations on the right. 
Since QUEST does not provide error estimates of summed metabolite areas, some diagrams 
are missing. It should also be noted, that for Crtot (where we do indicate CRLB values even in 
the case of QUEST), we had included a base spectrum for a 50/50 mixture of Cr and PCr, 
rather than individual spectra in the case of QUEST. For Abbreviations, see Fig. 2. 
 
Figure 5: Illustration of sample in vivo data with different LWs, SNRs, voxel location and TEs. 
The top row shows the single shot water scan. The water line width is calculated, and based on 
the TE and voxel composition, the SNR is estimated. The middle row shows simulated water 
suppressed spectra representing the estimated SNR and LW as well as the predicted CRLB 
from the look-up table. Note that the simulated spectrum is just for illustration and that the SNR 
and LW do not match exactly. The bottom row shows the subsequently acquired in vivo 
metabolite spectra and the corresponding CRLB obtained from fitting these spectra. 
 
Figure 6: Illustration of the in vivo performance of the proposed error forecast method for the 
case of LCModel at short TE. The graphs on the left show the correlation between the forecast 
error using the single water shot and the CRLB as determined from fitting the corresponding 
water-suppressed spectra, while on the right the same data is presented in the form of Bland-
Altman plots. The gray line on the correlation plot is the identity line. The Bland-Altman plots 
include 95 % confidence intervals for the differences and the significance values for these 
offsets. 
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Figure 7: Illustration of the in vivo performance of the proposed error forecast method for the 
case of LCModel at long TE. The graphs on the left show the correlation between the forecast 
error using the single water shot and the CRLB as determined from fitting the corresponding 
water-suppressed spectra, while on the right the same data is presented in the form of Bland-
Altman plots. The gray line on the correlation plot is the identity line. The Bland-Altman plots 
include 95 % confidence intervals for the differences and the significance values for these 
offsets. 
 
Figure 8: Illustration of the in vivo performance of the proposed error forecast method for the 
case of QUEST at short TE. The graphs on the left show the correlation between the forecast 
error using the single water shot and the CRLB as determined from fitting the corresponding 
water-suppressed spectra, while on the right the same data is presented in the form of Bland-
Altman plots. The gray line on the correlation plot is the identity line. The Bland-Altman plots 
include 95 % confidence intervals for the differences and the significance values for these 
offsets. 
 
Figure 9: Illustration of the in vivo performance of the proposed error forecast method for the 
case of QUEST at long TE. The graphs on the left show the correlation between the forecast 
error using the single water shot and the CRLB as determined from fitting the corresponding 
water-suppressed spectra, while on the right the same data is presented in the form of Bland-
Altman plots. The gray line on the correlation plot is the identity line. The Bland-Altman plots 
include 95 % confidence intervals for the differences and the significance values for these 
offsets. 
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Figure 1: Flowchart illustrating the forecasting procedure. The steps marked in blue are calculated by the 
toolbox while the steps marked in pink represent input by the user.  
Figure 1  
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Figure 2: Illustration of the fits in LCModel and QUEST for simulated PRESS 1H-MR spectra at TE=30 ms. a) 
FWHM = 7 Hz, SNR = 20; b) FWHM = 2 Hz (Lorentzian lineshape), no noise added; c) FWHM = 10 Hz (Voigt 
lineshape), no noise added. The residuals (original spectrum minus fit) are shown above the spectra. For 
QUEST, the original spectra and their corresponding fits were zero-filled before plotting for better 
comparison, since zero-filling is part of the LCModel data treatment.  
Figure 2  
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Figure 3: Mean variance for some estimated metabolite content obtained for simulated spectra at short TE 
when fit with LCModel (a) and QUEST (b). For both cases, the mean CRLB is shown on the left and standard 
deviations of the determined metabolite contents as obtained over 100 different noise realizations on the 
right.\r\nSince QUEST does not provide error estimates of summed metabolite areas, some diagrams are 
missing. It should also be noted, that for Crtot (where we do indicate CRLB values even in the case of 
QUEST), we had included a base spectrum for a 50/50 mixture of Cr and PCr, rather than individual spectra 
in the case of QUEST.\r\nAbbreviations: Chotot = Glycerophosphocholine + Phosphocholine; Cr = Creatine; 
CRLB = Cramer-Rao-lower bound; Crtot = Creatine + Phosphocreatine; Glx = Glutamate + Glutamine; 
mItot = myo-Inositol + Glyine; NAAtot = N-acetylaspartate + N-acetylaspartyl-glutamate; PCr = 
Phosphocreatine; TrueSD= true standard deviation.  
Figure 3  
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Figure 4: Mean variance for some estimated metabolite content obtained for simulated spectra at long TE 
when fit with LCModel (a) and QUEST (b). For both cases, the mean CRLB is shown on the left and standard 
deviations of the determined metabolite contents as obtained over 100 different noise realizations on the 
right.\r\nSince QUEST does not provide error estimates of summed metabolite areas, some diagrams are 
missing. It should also be noted, that for Crtot (where we do indicate CRLB values even in the case of 
QUEST), we had included a base spectrum for a 50/50 mixture of Cr and PCr, rather than individual spectra 
in the case of QUEST. For Abbreviations, see Fig. 2.  
Figure 4  
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Figure 5: Illustration of sample in vivo data with different LWs, SNRs, voxel location and TEs. The top row 
shows the single shot water scan. The water line width is calculated, and based on the TE and voxel 
composition, the SNR is estimated. The middle row shows simulated water suppressed spectra representing 
the estimated SNR and LW as well as the predicted CRLB from the look-up table. Note that the simulated 
spectrum is just for illustration and that the SNR and LW do not match exactly. The bottom row shows the 
subsequently acquired in vivo metabolite spectra and the corresponding CRLB obtained from fitting these 
spectra.  
Figure 5  
164x154mm (600 x 600 DPI)  
 
 
Page 25 of 49
Magnetic Resonance in Medicine
Magnetic Resonance in Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure 6: Illustration of the in vivo performance of the proposed error forecast method for the case of 
LCModel at short TE. The graphs on the left show the correlation between the forecast error using the single 
water shot and the CRLB as determined from fitting the corresponding water-suppressed spectra, while on 
the right the same data is presented in the form of Bland-Altman plots. The gray line on the correlation plot 
is the identity line. The Bland-Altman plots include 95 % confidence intervals for the differences and the 
significance values for these offsets.  
Figure 6  
140x112mm (300 x 300 DPI)  
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Figure 7: Illustration of the in vivo performance of the proposed error forecast method for the case of 
LCModel at long TE. The graphs on the left show the correlation between the forecast error using the single 
water shot and the CRLB as determined from fitting the corresponding water-suppressed spectra, while on 
the right the same data is presented in the form of Bland-Altman plots. The gray line on the correlation plot 
is the identity line. The Bland-Altman plots include 95 % confidence intervals for the differences and the 
significance values for these offsets.  
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Figure 8: Illustration of the in vivo performance of the proposed error forecast method for the case of 
QUEST at short TE. The graphs on the left show the correlation between the forecast error using the single 
water shot and the CRLB as determined from fitting the corresponding water-suppressed spectra, while on 
the right the same data is presented in the form of Bland-Altman plots. The gray line on the correlation plot 
is the identity line. The Bland-Altman plots include 95 % confidence intervals for the differences and the 
significance values for these offsets.  
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Figure 9: Illustration of the in vivo performance of the proposed error forecast method for the case of 
QUEST at long TE. The graphs on the left show the correlation between the forecast error using the single 
water shot and the CRLB as determined from fitting the corresponding water-suppressed spectra, while on 
the right the same data is presented in the form of Bland-Altman plots. The gray line on the correlation plot 
is the identity line. The Bland-Altman plots include 95 % confidence intervals for the differences and the 
significance values for these offsets.  
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